BGLAF
Price
$9.58
Change
-$0.92 (-8.76%)
Updated
Dec 3 closing price
Capitalization
1B
CRYM
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
27.72M
Interact to see
Advertisement

BGLAF vs CRYM

Header iconBGLAF vs CRYM Comparison
Open Charts BGLAF vs CRYMBanner chart's image
Biogaia AB
Price$9.58
Change-$0.92 (-8.76%)
Volume$2.65K
Capitalization1B
Cryomass Technologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$40.4K
Capitalization27.72M
BGLAF vs CRYM Comparison Chart in %
Loading...
CRYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGLAF vs. CRYM commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGLAF is a Hold and CRYM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BGLAF: $9.58 vs. CRYM: $0.03)
Brand notoriety: BGLAF and CRYM are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BGLAF: 100% vs. CRYM: 99%
Market capitalization -- BGLAF: $1B vs. CRYM: $27.72M
BGLAF [@Pharmaceuticals: Other] is valued at $1B. CRYM’s [@Pharmaceuticals: Other] market capitalization is $27.72M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGLAF’s FA Score shows that 2 FA rating(s) are green whileCRYM’s FA Score has 0 green FA rating(s).

  • BGLAF’s FA Score: 2 green, 3 red.
  • CRYM’s FA Score: 0 green, 5 red.
According to our system of comparison, BGLAF is a better buy in the long-term than CRYM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRYM’s TA Score shows that 4 TA indicator(s) are bullish.

  • CRYM’s TA Score: 4 bullish, 3 bearish.

Price Growth

BGLAF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while CRYM (@Pharmaceuticals: Other) price change was -0.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGLAF($1B) has a higher market cap than CRYM($27.7M). CRYM YTD gains are higher at: 59.170 vs. BGLAF (0.000). BGLAF has higher annual earnings (EBITDA): 529M vs. CRYM (-9.46M). BGLAF has more cash in the bank: 1.37B vs. CRYM (664K). BGLAF has higher revenues than CRYM: BGLAF (1.21B) vs CRYM (0).
BGLAFCRYMBGLAF / CRYM
Capitalization1B27.7M3,614%
EBITDA529M-9.46M-5,591%
Gain YTD0.00059.170-
P/E Ratio25.58N/A-
Revenue1.21B0-
Total Cash1.37B664K206,325%
Total DebtN/A2M-
FUNDAMENTALS RATINGS
CRYM: Fundamental Ratings
CRYM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGLAFCRYM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
21%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
20%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CRYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NINOF9.60N/A
N/A
Nikon Corp.
PBKOF16.32N/A
N/A
Pollard Banknote Ltd.
ROVMD0.14N/A
N/A
Rover Critical Minerals Corp
ASMIY604.17-7.62
-1.25%
ASM International N.V.
SLTTF0.23-0.04
-16.17%
RAVELIN PPTYS REIT

BGLAF and

Correlation & Price change

A.I.dvisor tells us that BGLAF and CTTH have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and CTTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
CTTH - BGLAF
23%
Poorly correlated
-0.31%
CRYM - BGLAF
21%
Poorly correlated
-1.43%
SHPH - BGLAF
8%
Poorly correlated
-1.51%
PLNH - BGLAF
3%
Poorly correlated
+6.02%
SDZNY - BGLAF
2%
Poorly correlated
+0.22%
More

CRYM and

Correlation & Price change

A.I.dvisor tells us that CRYM and BGLAF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRYM and BGLAF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRYM
1D Price
Change %
CRYM100%
-1.43%
BGLAF - CRYM
21%
Poorly correlated
N/A
PHCUF - CRYM
20%
Poorly correlated
N/A
TKPHF - CRYM
12%
Poorly correlated
N/A
VTRS - CRYM
7%
Poorly correlated
-0.21%
AYRWF - CRYM
6%
Poorly correlated
-4.96%
More